Supplier profile
Sandoz Farmacéutica, S. A.
Every public-sector award we hold for this supplier, across Spain, from 11 Mar 2009 to 4 Aug 2026.
Awards won
433
all time
Attributed value
€118.0m
229 shared, unvalued
Buyers
162
public bodies
Active
2009–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Consorci de Salut i d'Atenció Social de Catalunya | 31 | not attributable |
| Servicio Cántabro de Salud | 31 | €1.6m |
| Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 13 | €7.0m |
| Osakidetza | 11 | €1.5m |
| Secretaria General del Servicio de Salud de Castilla-La Mancha | 11 | €7.2m |
| Servicio Murciano de Salud | 11 | €1.2m |
| Consorci Sanitari Integral | 10 | not attributable |
| OSAKIDETZA - Servicio Vasco de Salud - Organización Central | 8 | €12.6m |
| Servicio Gallego de Salud | 8 | €1.5m |
| Consorci Sanitari de Terrassa | 7 | not attributable |
What they win
Awards
Showing 51–75 of 433 awards we hold
- Spain – Various medicinal products – Contrato basado del Acuerdo Marco para el suministro de medicamentos INMUNOSUPRESORES SELECTIVOS ↗AGRUPACIÓ EUROPEA DE COOPERACIÓ TERRITORIAL - HOSPITAL DE CERDANYAshared awardawarded 12 Mar 2025
- suministro de SOMATROPINA OMNITROPE lote 6 del AM 2021/064 para cubrir las necesidades del Servicio de Farmacia del Hospital Clínico Universitario de Valladolid ↗Gerencia de Atención Especializada Hospital Clínico Univ. de Valladolid€12kawarded 10 Mar 2025
- Spain – Pharmaceutical products – EXP. 2024-104 Suministro de medicamentos diversos II con destino el Hospital Clínic de Barcelona (HCB). ↗CONSORCI HOSPITAL CLÍNIC DE BARCELONA (HCB)shared awardawarded 7 Mar 2025
- Medicamentos biológicos con biosimilares (AM INGESA 2021/064) ↗Servicio Cántabro de Salud€332kawarded 14 Feb 2025
- Medicamentos biológicos con biosimilares (AM INGESA 2021/064) ↗Servicio Cántabro de Salud€48kawarded 14 Feb 2025
- Spain – Various medicinal products – Suministro de fármacos biológicos con biosimilar ↗Fundació de Gestió Sanitària de l’Hospital de la Santa Creu i Sant Paushared awardawarded 28 Jan 2025
- Spain – Pharmaceutical products – AM SUMINISTRO MEDICAMENTOS C (CCA. +6.C92WEGQ) SIGLO. 366/2024 ↗Servicio Andaluz de Salud. Hospital Universitario Virgen de las Nievesshared awardawarded 3 Jan 2025
- Spain – Various medicinal products – Adjudicación del Contrato Específico derivado del Sistema Dinámico de Adquisición del Suministro del Medicamento USTEKINUMAB para GESTIÓ PIUS HOSPITAL DE VALLS ↗Gestió Pius Hospital de Valls, SAMshared awardawarded 24 Dec 2024
- Spain – Antineoplastic and immunomodulating agents – Medicamentos biológicos con biosimilares (AM INGESA 2021/064) ↗Servicio Cántabro de Saludshared awardawarded 20 Dec 2024
- Spain – Antineoplastic and immunomodulating agents – Medicamentos biológicos con biosimilares (AM INGESA 2021/064) ↗Servicio Cántabro de Saludshared awardawarded 20 Dec 2024
- Medicamentos biológicos con biosimilares (AM INGESA 2021/064) ↗Servicio Cántabro de Salud€253kawarded 20 Dec 2024
- Medicamentos biológicos con biosimilares (AM INGESA 2021/064) ↗Servicio Cántabro de Salud€2kawarded 20 Dec 2024
- Suministro de Medicamentos de Uso Humano I, incluidos en el Grupo Terapéutico L, ( Antineoplásicos e Inmunomoduladores ) de la Clasificación ATC, basado en Acuerdo Marco expediente: 23/S/20/SU/DG/A/AM18. ↗Gerencia de Servicio Sanitarios de Fuerteventura€2kawarded 19 Dec 2024
- ta2025 suministro de etanercept biosimilar erelzi- hcd l2 derivado de a.m. 2021/064 ingesa (01-01-2025 hasta 15-12-2025)
 ↗Inspección General de Sanidad de la Defensa€72kawarded 12 Nov 2024
- suministro de rituximab biosimilar rixathon ↗Inspección General de Sanidad de la Defensa€67kawarded 12 Nov 2024
- ta2025 suministro de hyrimoz adalimumab biosimilar - hcd l1 derivado de a.m. 2021/064 ingesa (01-01-2025 hasta 15-12-2025)
 ↗Inspección General de Sanidad de la Defensa€87kawarded 31 Oct 2024
- Medicamentos Biológicos con Biosimilares (AM INGESA 2021/064) 76432700 ↗Servicio Cántabro de Salud€9kawarded 29 Oct 2024
- Spain – Pharmaceutical products – 2024-33 Suministro de medicamentos diversos para el Hospital Clínic de Barcelona. ↗CONSORCI HOSPITAL CLÍNIC DE BARCELONA (HCB)shared awardawarded 17 Sept 2024
- Medicamentos Bilógicos con biosimilares 75666800 75666900 75669800 75796800 75888000 ↗Servicio Cántabro de Salud€18kawarded 31 Aug 2024
- Suministro de los principios activos adalimumab (20, 40 y 80 mg), rituximab (100 y 500 mg) y trastuzumab (150 y 420 mg), con destino el Hospital Universitario de La Palma ↗Gerencia de los servicios Sanitarios del Area de Salud de La Palma€2kawarded 28 Aug 2024
- Spain – Pharmaceutical products – Acuerdo Marco de suministro (CONTR 2023 0000714922) ↗SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REINA SOFÍAshared awardawarded 20 Aug 2024
- Spain – Pharmaceutical products – suministro de medicamentos genéricos (complementario 2024) para los centros del Institut Català de la Salut (ICS) y centros adheridos a este procedimiento: Instituto de Assistència Sanitària (IAS) y Consorci Mar Parc Salut (PSMAR) ↗Institut Català de la Salutshared awardawarded 13 Aug 2024
- Spain – Pharmaceutical products – Acuerdo Marco Suministro (CONTR 2023 0001153871) ↗Servicio Andaluz de Salud. Hospital Universitario de Jaén.shared awardawarded 8 Aug 2024
- Suministro de los principios activos Adalimumab (20,40,80 mg), Rituximab (100 y 500 mg.) y Trastuzumab (150 y 420 mg), contrato basado en Acuerdo Marco 23/S/23/SU/DG/A/AM15. ↗Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria€2.5mawarded 6 Aug 2024
- Spain – Pharmaceutical products – MEDICAMENTOS VARIOS (I) ↗CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELLshared awardawarded 25 Jul 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.